Core Viewpoint - The incident of "ultra-low bid" in the procurement process of Jiangxi University of Traditional Chinese Medicine Hospital raises serious concerns about the integrity and quality of medical equipment procurement [1][2] Group 1: Incident Overview - Jiangxi University of Traditional Chinese Medicine Hospital had a budget of 3 million yuan for the procurement of fully automatic biochemical immunoassay analysis equipment, but a company won the bid with a price of only 1,000 yuan [1] - The hospital has suspended the procurement activity following the public outcry regarding the suspiciously low bid [1][2] Group 2: Implications of Ultra-Low Bidding - The significant price discrepancy suggests potential collusion between the bidding parties, raising questions about the legitimacy of the bidding process and the quality of the products offered [1][2] - The phenomenon of "ultra-low bidding" in public hospital procurement is not isolated, with extreme cases reported, such as a complete production line being bid at 1 yuan [2] Group 3: Industry Concerns - The prevalence of "ultra-low bidding" undermines the competitive order in the medical industry, potentially leading to inferior quality products entering hospitals, which directly affects patient health [2] - The Ministry of Finance has recognized this issue and is piloting measures in cities like Beijing and Shanghai to address abnormal low-price bids, emphasizing the need for quality over price in procurement [2]